HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VDR gene ApaI polymorphism and risk of postmenopausal osteoporosis: a meta-analysis from 22 studies.

AbstractOBJECTIVE:
The ApaI polymorphism (G > T, rs7975232) of the vitamin D receptor (VDR) gene in the risk of postmenopausal osteoporosis has been widely researched, and the results have yielded conflicts. Therefore, we performed an updated pooled analysis to comprehensively assess the association between VDR ApaI polymorphism and postmenopausal osteoporosis risk.
METHODS:
We searched eligible studies about ApaI polymorphism and osteoporosis through the PubMed, Embase, CNKI and Wanfang databases; case-control studies containing available genotype frequencies of A/a were chosen. We used the odds ratio with 95% confidence interval to assess the strength of this association. Sensitivity analysis and publication bias assessment were performed. Trial sequential analysis (TSA) was performed to evaluate a sufficient sample.
RESULTS:
Twenty-two studies assessed the relationship between ApaI polymorphism and the risk of osteoporosis in postmenopausal women. The comprehensive analyses showed no significant association for ApaI polymorphism with postmenopausal osteoporosis in the overall population, equally valid for Asian and Caucasian subgroups with any genetic model. TSA still indicated the results were robust.
CONCLUSION:
The present meta-analysis suggests that the VDR ApaI genotype may not affect the risk of postmenopausal osteoporosis in Asians and Caucasians.
AuthorsB Wang, H Li, C Yang, R Nie, X Zhang, C Pu
JournalClimacteric : the journal of the International Menopause Society (Climacteric) Vol. 26 Issue 6 Pg. 583-593 (Dec 2023) ISSN: 1473-0804 [Electronic] England
PMID37477999 (Publication Type: Meta-Analysis, Journal Article)
Chemical References
  • Receptors, Calcitriol
  • VDR protein, human
Topics
  • Female
  • Humans
  • Osteoporosis, Postmenopausal (genetics)
  • Genetic Predisposition to Disease
  • Receptors, Calcitriol (genetics)
  • Polymorphism, Genetic
  • Osteoporosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: